The purpose of the study was to analyze the factors affecting sustainable growth of local pharmaceutical manufacturing companies by determining and establishing their influence on sustainable growth of these firms in Kenya. The review of related literature identified these factors as competition, government regulations, international regulations and the cost of production. The study adopted a cross sectional research design and targeted 32 local firms registered with the Pharmacy Poisons Board in 2016. Data was collected using a questionnaire and analyzed using descriptive and inferential statistics. Pearson’s correlation and regression analysis were used to test the influence of predictor variables on...

Access to affordable, safe, effective, and quality-assured medicines by a patient is important for good health outcomes. Unfortunately, there is sparse literature published on the pharmaceutical enablers that may increase the sale of a substandard and falsified (SF) medicine to a patient in Kenya. The review highlights some of the factors that may facilitate the entry of SF medicines into the legitimate pharmaceutical supply chain and discusses their impact on patient access to medicines. Lack of essential medicines in public health facilities is an important factor that may contribute to increased demand for medicine-related out-of-pocket expenses from private health facilities,...

The pharmaceutical landscape in Kenya constitutes a number of multinational companies that are present through locally incorporated affiliates, technical representative offices and local technical agents. The presence of these companies has made the industry more competitive, with an emphasis on maintaining both quality and affordability. Asoko has mapped the leading 25 players working across manufacturing, distribution and retail of pharmaceuticals and medical equipment. The industry is dominated by private companies, with 14 of the leading players being private companies. Among the rest, seven are multinationals and four are family owned.

The Kenya Pharmaceutical Industry Diagnostic Report 2020 highlights and examines gaps, challenges, and opportunities in Kenya’s pharmaceutical industry. The report recommends steps to spur the industry’s growth and make it more competitive

This is a best prospect industry sector for this country. Includes a market overview and trade data.